Cargando…
Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma is the fifth most common malignancy and the third leading cause of cancer-related death worldwide. Dysregulation of HomeoboxD10 (HOXD10) was found to suppress or promote cancer progression in different cancer types. The function and regulation of HOXD10 remain un...
Autores principales: | Guo, Yulin, Peng, Yaojun, Gao, Dan, Zhang, Meiying, Yang, Weili, Linghu, Enqiang, Herman, James G., Fuks, François, Dong, Guanglong, Guo, Mingzhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654145/ https://www.ncbi.nlm.nih.gov/pubmed/29075359 http://dx.doi.org/10.1186/s13148-017-0412-9 |
Ejemplares similares
-
Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma
por: Li, Hongxia, et al.
Publicado: (2018) -
Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer
por: Jia, Yan, et al.
Publicado: (2015) -
Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development
por: Wang, Ying, et al.
Publicado: (2017) -
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth
por: Dong, Yan, et al.
Publicado: (2015) -
Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
por: Wang, Yuzhu, et al.
Publicado: (2018)